TY  - GEN
AU  - Metzelder,S K
AU  - Schroeder,T
AU  - Lübbert,M
AU  - Ditschkowski,M
AU  - Götze,K
AU  - Scholl,S
AU  - Meyer,R G
AU  - Dreger,P
AU  - Basara,N
AU  - Fey,M F
AU  - Salih,H R
AU  - Finck,A
AU  - Pabst,T
AU  - Giagounidis,A
AU  - Kobbe,G
AU  - Wollmer,E
AU  - Finke,J
AU  - Neubauer,A
AU  - Burchert,A
TI  - Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
SN  - 1879-0852
PY  - 2017///1121
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Germany
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Leukemia, Myeloid, Acute
KW  - enzymology
KW  - Male
KW  - Middle Aged
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Recurrence
KW  - Remission Induction
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Sorafenib
KW  - Stem Cell Transplantation
KW  - Tandem Repeat Sequences
KW  - Time Factors
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Young Adult
KW  - fms-Like Tyrosine Kinase 3
N1  - Publication Type: Journal Article; Multicenter Study; Observational Study
UR  - https://doi.org/10.1016/j.ejca.2017.09.016
ER  -